GSK

News

GSK welcomes Brexit transition deal, but wants more 'precisi...

The chief executive of GlaxoSmithKline has welcomed the breakthrough in talks between the UK and EU27 countries on a transition or ‘implementation’ period.

News

GSK’s former chief Witty makes surprise move to ‘the dark si...

GlaxoSmithKline’s former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

News

Advair reprieve gives GSK breathing space

GlaxoSmithKline looks set to have another year without US generic competition to its respiratory blockbuster Advair, after the FDA raised problems with a challenger.

News

Rumours of $1.65bn GSK bid for respiratory partners Vectura

GlaxoSmithKline could be poised to acquire its respiratory partner, UK biotech Vectura, for $1.65bn.

News

GSK to take blood cancer drug into late-stage trials

UK firm to get back into cancer with GSK2857916

News

Eyes on GSK as Pfizer prepares to sell consumer division

GlaxoSmithKline saw its share price fall 6% yesterday after releasing underwhelming figures in Q3, and leaving investors uncertain about its future dividend payments.

GSK welcomes Brexit transition deal, but wants more 'precisi...

GSK’s former chief Witty makes surprise move to ‘the dark si...

Advair reprieve gives GSK breathing space

Rumours of $1.65bn GSK bid for respiratory partners Vectura

GSK to take blood cancer drug into late-stage trials

Eyes on GSK as Pfizer prepares to sell consumer division

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks